EcoDrugPlus

Renin

Ensembl ID : ENSMMDG00005010824
Gene Symbol: REN
1 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene Receptor Tyrosine Kinase

Ensembl ID : ENSMMDG00005011682
Gene Symbol: RET
1 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Rxr-Beta-A-Like

Ensembl ID : ENSMMDG00005011690
Gene Symbol: LOC115373331
3 Cross references
211 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSMMDG00005008540
Gene Symbol: RARB
1 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSMMDG00005011700
Gene Symbol: RARG
3 Cross references
353 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSMMDG00005022343
Gene Symbol: LOC115358830
3 Cross references
377 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSMMDG00005020143
Gene Symbol: LOC115356170
3 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSMMDG00005010307
Gene Symbol: ROCK2A
1 Cross references
225 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSMMDG00005015154
Gene Symbol: RPL10
3 Cross references
409 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSMMDG00005018817
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSMMDG00005004396
Gene Symbol: RPL11
1 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSMMDG00005009806
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).